608 related articles for article (PubMed ID: 26724648)
1. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of breast lesions by contrast enhanced ultrasound: qualitative and quantitative analysis.
Wan C; Du J; Fang H; Li F; Wang L
Eur J Radiol; 2012 Apr; 81(4):e444-50. PubMed ID: 21612882
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
[TBL] [Abstract][Full Text] [Related]
4. The place of CEUS in distinguishing benign from malignant cervical lymph nodes: a prospective study.
Poanta L; Serban O; Pascu I; Pop S; Cosgarea M; Fodor D
Med Ultrason; 2014 Mar; 16(1):7-14. PubMed ID: 24567918
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesions.
Janu E; Krikavova L; Little J; Dvorak K; Brancikova D; Jandakova E; Pavlik T; Kovalcikova P; Kazda T; Valek V
BMC Med Imaging; 2020 Jun; 20(1):66. PubMed ID: 32552678
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound.
Saracco A; Szabó BK; Aspelin P; Leifland K; Wilczek B; Celebioglu F; Axelsson R
Acta Radiol; 2012 May; 53(4):382-8. PubMed ID: 22434928
[TBL] [Abstract][Full Text] [Related]
7. Can different regions of interest influence the diagnosis of benign and malignant breast lesions using quantitative parameters of contrast-enhanced sonography?
Li J; Guo L; Yin L; Fang H; Ye W; Zhao B; Liu Y; Xu T
Eur J Radiol; 2018 Nov; 108():1-6. PubMed ID: 30396640
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.
Nemec U; Nemec SF; Novotny C; Weber M; Czerny C; Krestan CR
Eur Radiol; 2012 Jun; 22(6):1357-65. PubMed ID: 22322310
[TBL] [Abstract][Full Text] [Related]
9. The clinical role of contrast enhanced ultrasound in differential diagnosis of BI-RADS 4 breast disease.
Quan J; Hong Y; Zhang X; Mei M; You X; Huang P
Clin Hemorheol Microcirc; 2019; 72(3):293-303. PubMed ID: 30856103
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Multiparametric Breast Ultrasound: Application of Contrast-Enhanced Ultrasound and Elastography Leads to an Improved Differentiation of Benign and Malignant Lesions.
Kapetas P; Clauser P; Woitek R; Wengert GJ; Lazar M; Pinker K; Helbich TH; Baltzer PAT
Invest Radiol; 2019 May; 54(5):257-264. PubMed ID: 30632985
[TBL] [Abstract][Full Text] [Related]
11. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
Du YR; Wu Y; Chen M; Gu XG
Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
[TBL] [Abstract][Full Text] [Related]
12. Incorporating Contrast-Enhanced Ultrasound into the BI-RADS Scoring System Improves Accuracy in Breast Tumor Diagnosis: A Preliminary Study in China.
Xiao X; Dong L; Jiang Q; Guan X; Wu H; Luo B
Ultrasound Med Biol; 2016 Nov; 42(11):2630-2638. PubMed ID: 27544439
[TBL] [Abstract][Full Text] [Related]
13. Renal Masses: Evaluation with Contrast-Enhanced Ultrasound, with a Special Focus on the Pseudocapsule Sign.
Dai WB; Yu B; Diao XH; Cao H; Chen L; Chen Y; Zhan J
Ultrasound Med Biol; 2019 Aug; 45(8):1924-1932. PubMed ID: 31122812
[TBL] [Abstract][Full Text] [Related]
14. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
[TBL] [Abstract][Full Text] [Related]
15. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging.
Du J; Wang L; Wan CF; Hua J; Fang H; Chen J; Li FH
Eur J Radiol; 2012 Dec; 81(12):3890-9. PubMed ID: 23062280
[TBL] [Abstract][Full Text] [Related]
16. Comparison of transducers with different frequencies in breast contrast-enhanced ultrasound (CEUS) using SonoVue as contrast agent.
Wang YM; Fan W; Zhang K; Zhang L; Tan Z; Ma R
Br J Radiol; 2016 Jul; 89(1063):20151050. PubMed ID: 27143439
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of contrast-enhanced ultrasound qualitative and quantitative analysis for identifying benign and malignant breast tumor lumps.
Liu J; Gao YH; Li DD; Gao YC; Hou LM; Xie T
Asian Pac J Cancer Prev; 2014; 15(19):8149-53. PubMed ID: 25338998
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
Park AY; Kwon M; Woo OH; Cho KR; Park EK; Cha SH; Song SE; Lee JH; Cha J; Son GS; Seo BK
Korean J Radiol; 2019 May; 20(5):759-772. PubMed ID: 30993927
[TBL] [Abstract][Full Text] [Related]
19. The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.
Zhang F; Jin L; Li G; Jia C; Shi Q; Du L; Wu R
Br J Radiol; 2021 Apr; 94(1120):20200880. PubMed ID: 33560894
[TBL] [Abstract][Full Text] [Related]
20. Quantification of enhancement of renal parenchymal masses with contrast-enhanced ultrasound.
Cai Y; Du L; Li F; Gu J; Bai M
Ultrasound Med Biol; 2014 Jul; 40(7):1387-93. PubMed ID: 24768490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
